ADAMTS13 and androgen insensitivity syndrome: In the present study, we examined the antigen level of ADAMTS13 before thrombolysis in 163 AIS patients and found the ADAMTS13 level was lower in patients with mRS >2 at 90 days, but it was not independently associated with the outcome after adjusting for all confounding factors.